Biomerica Inc (BMRA) stock price

Biomerica Inc (BMRA) is a Healthcare · Medical Devices company listed on NASDAQ. Price $2.36 (+0.00%), Market cap $0.01B, 52-week low–high $1.92 ~ $4.14.

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intoleranc

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Biomerica Inc are updated in real time on BlackAll Trade.

Biomerica Inc financial summary

Key ratios · profitability · growth

Frequently asked questions

What is the current Biomerica Inc (BMRA) stock price?

Biomerica Inc trades at $2.36 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.

What is the Biomerica Inc (BMRA) market cap?

Biomerica Inc has a market cap of about $0.01B.

What does Biomerica Inc (BMRA) do?

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditio